If the patient is approved, the GSK Co-pay Program may help with the patient's cost share for the GSK product, and the cost of administration, up to $100 per administration, up to a program total of $15,000 annually. Residents of Massachusetts, Minnesota or Rhode Island, are not eligible for reimbursement of administrative fees..